Clinical Trial Update: A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial in bladder cancer comparing chemotherapy with OGX-427 versus placebo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• OGX-427 (apatorsen)

Snippet

Sponsor: Achieve Life Sciences | Conditions: Urologic Neoplasms, Metastatic Bladder Cancer | Phase 2 | Status: COMPLETED